Senior Director, HCP Marketing Lead at Zenas BioPharma | Waltham, MA | $218K/yr – $272K/yr

Zenas BioPharma

Senior Director, HCP Marketing Lead

Waltham, MA (On-site)

$218K/yr – $272K/yrSenior LevelFull time

Posted 5 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive Obexelimab brand strategy and cross-functional launch readiness for US market, ensuring aligned messaging and data-driven optimization.

Own Obexelimab brand strategy and cross-functional launch readiness.
Must-have: Deep US market experience with omnichannel marketing.
Standout: Leadership across Sales, Medical Affairs, and Compliance.

Job Description

Responsibilities

Lead the development of Obexelimab brand strategies, focusing on product positioning, messaging, and market differentiation.
Lead Cross-functionnal launch readiness governance and execution for Obexelimab in IgG4-RD
Represent US Marketing on the Obexelimab US Brand Team, collaborating on strategies, messaging, and materials to ensure consistency strategic alignment across function.
Ensure strong collaboration between the US Marketing team and counterparts on cross-functional teams, including Sales, Access & Trade, Strategic Engagement, Analytics, Medical Affairs, Compliance, Legal and Regulatory and Patient Support Services.
Utilize market and customer insights to inform key business decisions and refine brand and customer strategies.
Establish core messaging for a diverse customer base, including HCPs & KOL.
Lead the creation of HCP marketing assets (disease education and promotional materials), including development, review, approval that aligns with brand positioning, messaging, and regulatory guidelines
Lead the creation of a Market Development strategy including the development, review and approval of all materials associated with market development activities
Collaborate closely with Strategic Engagement to collect relevant insights for the Brand Strategy, and build and execute the market development plan (Congress, Ad board, Speaker Bureau…)
Lead customer segmentation efforts to optimize outreach and engagement across channels and ensure precise targeting.

Requirements

Bachelor’s degree required; advanced degree in business or life sciences preferred.
Deep marketing experience required.
I&I &/or Rare Diseases experience preferred.
Deep understanding of the US Market Dynamics
Exceptional communication and analytical skills, with a focus on high-impact execution and results.
Proven success in customer-centric marketing strategy development and cross-functional leadership
Strong project management skills with the ability to manage multiple projects simultaneously while meeting tight deadlines
Established Marketing skills.
HCP, Account, & Digital marketing experience with multiple brands. Demonstrated expertise in omnichannel, modular marketing and content / channel strategy.
Ability to travel up to 33%.

Preferred

Field experience will be a plus
Advanced degree in business or life sciences (preferred)
I&I &/or Rare Diseases experience preferred

Benefits

The base salary pay range for this role is $217,600 to $272,000.
The position is eligible for a competitive compensation and benefits package.
Zenas believes in providing a competitive compensation and benefits package to all employees. Our base salary is just one component of Zenas’ competitive total rewards strategy that also includes annual performance bonus, equity, full range of benefits and other incentive compensation plans.

Zenas BioPharma

5.0 Glassdoor

Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease.

Founded in 2020

Waltham, Massachusetts, USA

148 employees (5 in marketing)

zenasbio.com

100% recommend to a friend